Free Trial

Enliven Therapeutics (ELVN) Institutional Ownership

Enliven Therapeutics logo
$41.36 -1.03 (-2.43%)
Closing price 04:00 PM Eastern
Extended Trading
$41.37 +0.01 (+0.02%)
As of 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Enliven Therapeutics (NASDAQ:ELVN)

Current
Institutional Ownership
Percentage
95.08%
Number of
Institutional Buyers
(last 12 months)
89
Total
Institutional Inflows
(last 12 months)
$729.04M
Number of
Institutional Sellers
(last 12 months)
33
Total
Institutional Outflows
(last 12 months)
$184.08M
Get ELVN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Enliven Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ELVN Institutional Buying and Selling by Quarter

Enliven Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/9/2026First Light Asset Management LLC1,360,750$69.06M4.2%+574.1%1.857%
9/9/2026Tidal Investments LLC60,694$3.08M0.0%+27.7%0.083%
9/9/2026WINTON GROUP Ltd4,495$228K0.0%N/A0.006%
9/9/2026Engineers Gate Manager LP29,152$1.48M0.0%N/A0.040%
9/9/2026Squarepoint Ops LLC5,099$259K0.0%N/A0.007%
9/8/2026Arizona State Retirement System13,007$660K0.0%+45.1%0.018%
9/2/2026Allianz Asset Management GmbH52,008$2.64M0.0%N/A0.071%
8/26/2026Amundi6,041$307K0.0%-12.9%0.008%
8/21/2026AXQ Capital LP10,095$512K0.1%-5.1%0.014%
8/19/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC80,072$4.06M0.0%+18.7%0.109%
8/19/2026Wellington Management Group LLP133,143$6.76M0.0%-11.3%0.182%
8/17/2026Capstone Investment Advisors LLC10,577$537K0.0%N/A0.014%
8/17/2026Seven Fleet Capital Management LP365,386$18.54M3.1%+40.9%0.499%
8/17/2026Artia Global Partners LP72,100$3.66M0.7%N/A0.098%
8/17/2026Bamco Inc. NY7,500$381K0.0%N/A0.010%
8/17/2026Bank of America Corp DE98,023$4.98M0.0%N/A0.134%
8/15/2026Jupiter Topco LLC604,122$30.62M0.0%N/A0.825%
8/15/2026J. Goldman & Co LP112,129$5.69M0.1%N/A0.153%
8/14/2026ADAR1 Capital Management LLC387,718$19.68M0.9%N/A0.529%
8/14/2026Canada Pension Plan Investment Board15,400$782K0.0%N/A0.021%
8/14/2026Nicholas Investment Partners LP391,529$19.87M1.1%N/A0.534%
8/14/2026Legal & General Group Plc32,924$1.67M0.0%N/A0.045%
8/14/2026The Manufacturers Life Insurance Company75,265$3.82M0.0%N/A0.103%
8/14/2026Spruce Street Capital LP329,006$16.70M0.0%N/A0.449%
8/14/2026Algert Global LLC72,090$3.66M0.0%N/A0.098%
8/13/2026Connor Clark & Lunn Investment Management Ltd.160,879$8.17M0.0%N/A0.220%
8/7/2026BlackRock Inc.4,359,704$221.26M0.0%N/A7.159%
8/7/2026Deutsche Bank AG45,109$2.29M0.0%N/A0.074%
8/7/2026TimesSquare Capital Management LLC261,344$13.26M0.2%N/A0.429%
8/7/2026Persistent Asset Partners Ltd9,433$479K0.1%N/A0.015%
8/6/2026Bank of New York Mellon Corp118,853$6.03M0.0%N/A0.195%
8/6/2026State of Wyoming1,884$96K0.0%N/A0.003%
7/10/2026Tema ETFs LLC60,694$3.08M0.1%+41.0%0.100%
7/10/2026Handelsbanken Fonder AB17,300$878K0.0%N/A0.028%
7/8/2026FNY Investment Advisers LLC2,500$126K0.0%N/A0.004%
7/8/2026Assenagon Asset Management S.A.306,574$15.56M0.0%N/A0.503%
6/4/2026Seven Fleet Capital Management LP259,283$10.16M3.2%+159.4%0.426%
6/3/2026DV Trading LLC95,253$3.73M0.1%N/A0.156%
5/28/2026Avidity Partners Management LP400,000$15.68M3.1%+185.1%0.657%
5/19/2026Bank of America Corp DE45,162$1.77M0.0%+38.1%0.074%
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company (Ad)

We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel

👉 Unlock the ticker now and get it completely free.
5/19/2026Stempoint Capital LP363,438$14.25M2.7%N/A0.597%
5/19/2026Janus Henderson Group PLC11,000$431K0.0%-99.3%0.018%
5/18/2026ADAR1 Capital Management LLC329,540$12.92M0.8%+998.5%0.541%
5/18/2026Amundi6,936$272K0.0%N/A0.011%
5/18/2026California State Teachers Retirement System31,914$1.25M0.0%-0.9%0.052%
5/18/2026Royal Bank of Canada5,424$212K0.0%+345.0%0.009%
5/18/2026Rock Springs Capital Management LP826,500$32.40M1.9%+3.5%1.357%
5/18/2026Exome Asset Management LLC220,091$8.63M4.5%-1.0%0.361%
5/16/2026The Manufacturers Life Insurance Company23,441$919K0.0%+21.2%0.038%
5/16/2026Quantinno Capital Management LP6,538$256K0.0%N/A0.011%
5/16/2026First Light Asset Management LLC201,867$7.91M0.7%N/A0.331%
5/16/2026SummitTX Capital L.P.68,706$2.69M0.1%N/A0.113%
5/15/2026Commodore Capital LP3,275,000$128.38M7.4%-30.2%5.378%
5/15/2026Affinity Asset Advisors LLC586,904$23.01M1.2%N/A0.964%
5/15/2026Entropy Technologies LP6,101$239K0.0%N/A0.010%
5/15/2026Spruce Street Capital LP329,006$12.90M3.1%-26.2%0.540%
5/14/2026Siren L.L.C.746,226$29.25M0.8%N/A1.225%
5/14/2026Walleye Capital LLC37,827$1.48M0.0%N/A0.062%
5/7/2026Dimensional Fund Advisors LP681,715$26.71M0.0%+70.9%1.119%
5/7/2026KBC Group NV958$38K0.0%N/A0.002%
5/6/2026Jennison Associates LLC309,180$12.12M0.0%N/A0.508%
5/5/2026Bank of New York Mellon Corp120,057$4.71M0.0%+8.6%0.197%
5/1/2026Candriam S.C.A.594,079$23.29M0.1%+31.1%0.975%
4/24/2026Capricorn Fund Managers Ltd369,400$14.48M2.3%N/A0.607%
4/22/2026Pictet Asset Management Holding SA929,544$36.44M0.0%-28.7%1.526%
2/26/2026Seven Fleet Capital Management LP11,688$180K0.1%N/A0.020%
2/19/2026Invesco Ltd.24,720$381K0.0%+7.0%0.042%
2/18/2026XTX Topco Ltd60,702$935K0.0%+472.6%0.102%
2/18/2026Vestal Point Capital LP3,830,000$58.98M2.0%+230.2%6.454%
2/18/2026Virtus Investment Advisers LLC15,778$243K0.1%+172.6%0.027%
2/18/2026Wellington Management Group LLP129,876$2M0.0%+19.6%0.219%
2/18/2026Susquehanna Portfolio Strategies LLC48,741$751K0.0%+53.6%0.082%
2/18/2026Tudor Investment Corp ET AL29,673$457K0.0%+82.0%0.050%
2/18/2026Sphera Funds Management LTD.226,765$3.49M0.7%+36.0%0.382%
2/18/2026Millennium Management LLC296,947$4.57M0.0%-22.1%0.500%
2/18/2026Janus Henderson Group PLC1,671,724$25.75M0.0%-6.8%2.817%
2/18/2026Baker BROS. Advisors LP271,406$4.18M0.0%+136.3%0.457%
2/17/2026ADAR1 Capital Management LLC30,000$462K0.0%N/A0.051%
2/17/2026Jump Financial LLC45,354$698K0.0%N/A0.076%
2/17/2026Price T Rowe Associates Inc. MD23,800$367K0.0%-89.7%0.040%
2/17/2026Rock Springs Capital Management LP798,405$12.30M0.6%+16.4%1.345%
2/17/2026California State Teachers Retirement System32,206$496K0.0%+58.4%0.054%
2/17/2026Russell Investments Group Ltd.3,121$48K0.0%-14.3%0.005%
2/17/2026State of Wisconsin Investment Board20,398$314K0.0%-57.2%0.034%
2/17/2026ExodusPoint Capital Management LP60,415$930K0.0%+25.5%0.102%
2/17/2026Polar Capital Holdings Plc3,513,680$54.11M0.2%+13.5%5.920%
2/16/2026Squarepoint Ops LLC20,763$320K0.0%-42.1%0.035%
2/16/2026Spruce Street Capital LP446,084$6.87M2.3%N/A0.752%
2/16/2026Barclays PLC69,875$1.08M0.0%-1.2%0.118%
2/13/2026Marshall Wace LLP371,906$5.73M0.0%+9.2%0.627%
The $15 Gold Fund That Pays Up to $1,152/Month (Ad)

Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel

Discover the gold income fund before the next payout date
2/13/2026The Manufacturers Life Insurance Company 19,336$298K0.0%-56.1%0.033%
2/13/2026Exome Asset Management LLC222,308$3.42M1.6%N/A0.375%
2/13/2026Charles Schwab Investment Management Inc.355,192$5.47M0.0%-2.2%0.598%
2/13/2026State Street Corp1,052,862$16.21M0.0%+9.1%1.774%
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC55,210$850K0.0%+6.8%0.093%
2/13/2026Wells Fargo & Company MN43,056$663K0.0%+66.7%0.073%
2/12/2026Dimensional Fund Advisors LP398,893$6.14M0.0%+148.6%0.672%
2/12/2026Patient Square Capital LP308,141$4.75M1.0%+22.8%0.519%
2/12/2026New York State Common Retirement Fund9,097$140K0.0%-39.7%0.015%
2/12/2026Swiss National Bank64,273$990K0.0%+1.7%0.108%


ELVN Institutional Ownership - Frequently Asked Questions

During the previous two years, 141 institutional investors and hedge funds held shares of Enliven Therapeutics. The most heavily invested institutionals were BlackRock Inc. ($221.26M), FMR LLC ($146.16M), Commodore Capital LP ($128.38M), First Light Asset Management LLC ($69.06M), Vestal Point Capital LP ($58.98M), Polar Capital Holdings Plc ($54.11M), and Vanguard Group Inc. ($52.26M).Learn more on Enliven Therapeutics' institutional investors.

95.08% of Enliven Therapeutics' stock is owned by institutional investors. Learn more on ELVN's institutional investor holdings.

Of the 123 institutional investors that purchased Enliven Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($4.36M), Vestal Point Capital LP ($3.58M), Polar Capital Holdings Plc ($2.20M), First Light Asset Management LLC ($1.36M), Affinity Asset Advisors LLC ($986.90K), Duquesne Family Office LLC ($947.41K), and FMR LLC ($801.30K).

Institutional investors have bought a total of 19,991,057 shares in the last 24 months. This purchase volume represents approximately $729.04M in transactions.

Of the 33 institutional investors that sold Enliven Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Janus Henderson Group PLC ($1.78M), Commodore Capital LP ($1.42M), Woodline Partners LP ($800.16K), Pictet Asset Management Holding SA ($468.54K), Franklin Resources Inc. ($410.07K), Citadel Advisors LLC ($309.92K), and Price T Rowe Associates Inc. MD ($207.50K).

Institutional investors have sold a total of 5,965,858 shares in the last 24 months. This volume of shares sold represents approximately $184.08M in transactions.



Institutional ownership data for NASDAQ:ELVN is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/9/2026. New 13F filings are added each quarter as they're published.
From Our Partners